אדרונקס Izrael - héber - Ministry of Health

אדרונקס

pfizer pfe pharmaceuticals israel ltd - reboxetine methan sulfonate - טבליה - reboxetine methan sulfonate 4 mg - reboxetine - reboxetine - reboxetine is indicated for the acute treatment of depressive illness/major depression and for maintaining the clinical improvement in patients initially responding to treatment.

פריסטיק 50 מ"ג Izrael - héber - Ministry of Health

פריסטיק 50 מ"ג

neopharm ltd - desvenlafaxine as succinate 50 mg - tablets extended release - desvenlafaxin - pristiq , a selective serotonin and norepinephrine reuptake inhibitor (snri) , is indicated for the treatment of major depressive disorder (mdd).

פריסטיק 100 מ"ג Izrael - héber - Ministry of Health

פריסטיק 100 מ"ג

neopharm ltd - desvenlafaxine as succinate 100 mg - tablets extended release - desvenlafaxin - pristiq , a selective serotonin and norepinephrine reuptake inhibitor (snri) , is indicated for the treatment of major depressive disorder (mdd).

טליבריקס 30 מגלומין Izrael - héber - Ministry of Health

טליבריקס 30 מגלומין

promedico ltd - meglumine ioxitalamate - תמיסה להזרקה - meglumine ioxitalamate 66.03 g / 100 ml - meglumine antimonate - meglumine antimonate - for urograph, selective angiography, peripheral angiography, arthrography, hysterosalpingography and digestive exploration.

איומרון 300 Izrael - héber - Ministry of Health

איומרון 300

dexcel ltd, israel - iomeprol - תמיסה להזרקה - iomeprol 612.4 mg/ml - iomeprol - iomeprol - contrast medium for diagnostic radiology. intravenous urography ( in adults and paediatrics), peripheral phlebography, ct (brain and body), cavernosography, intravenous dsa, conventional angiography, intraarterial dsa, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ercp, arthrography, hysterosalpingography, fistulography, discography, galactography, chloangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.

ליקרביום Izrael - héber - Ministry of Health

ליקרביום

rekah pharmaceutical industry ltd, israel - lithium carbonate - טבליה - lithium carbonate 300 mg - lithium - treatment of manic depressive states.

איומרון 350 Izrael - héber - Ministry of Health

איומרון 350

dexcel ltd, israel - iomeprol - תמיסה להזרקה - iomeprol 714.4 mg/ml - watersoluble, nephrotropic, low osmolar x-ray contrast media - contrast medium for diagnostic radiography. intravenous urography (in adults and pediatrics), ct (body), intravenous dsa, conventional angiography, intraarterial dsa, angiocardiography (in adults and pediatrics), conventional selective coronary arteriography, interventional coronary arteriography , arthrography, hysterosalpingography, fistulography, galactography, retrograde chloangiography, dacryocystography, sialography.

איומרון 400 Izrael - héber - Ministry of Health

איומרון 400

dexcel ltd, israel - iomeprol - תמיסה להזרקה - iomeprol 816.5 mg/ml - watersoluble, nephrotropic, low osmolar x-ray contrast media - contrast medium for diagnostic radiography. intravenous urography (in adults ,including those with renal impairment or diabetes), ct (body), conventional angiography, intraarterial dsa, angiocardiography (in adults and pediatrics), conventional selective coronary arteriography, interventional coronary , arthrography, fistulography, galactography, dacryocystography, sialography.

נורמיטן 25 Izrael - héber - Ministry of Health

נורמיטן 25

abic ltd. - atenolol - טבליה - atenolol 25 mg - beta blocking agents, selective - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction.

מרוניל 25 Izrael - héber - Ministry of Health

מרוניל 25

unipharm ltd, israel - clomipramine hydrochloride - טבליה - clomipramine hydrochloride 25 mg - non selective monoamine reuptake inhibitors - depression of varying origin.in children and adolescents there is not sufficient evidence of safety and efficacy of maronil in the treatment of depressive states of varying aetiology and symptomatology. the use of maronil in children and adolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes.no experience is available in children younger than 5 years of age.